ArticleIntestinal research2022

Long-term clinical and real-world experience with Crohn's disease treated with anti-tumor necrosis factor-α antibodies.

Haruka Otake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.